Ona Therapeutics, which is focused on the discovery and development of therapeutic biologics to treat metastatic cancer,  announced today the closing of a €30 million Series A financing, with participation from existing investor Asabys Partners and new investors Alta Life Sciences, Bpifrance – InnoBio 2, Fund+ and Ysios Capital. You can read the full press release here